Stephanie Lewis: Unscripted

Caravel Autism Health's new clinic offers hope for families, highlighting Iowa's care shortages, recent insurance reforms, and a changing therapy landscape.

Visa taps InsurTech leader Neat to overhaul card insurance, starting in France, with AI-powered personalization and fully digital claims for 25M users.

IVY Rx unveils its 2026 compounded GLP-1 program with clear pricing, but operates in a market facing intense FDA warnings and regulatory uncertainty.

The global watch and jewelry giant opens a massive luxury hub, blending new Rolex, a booming pre-owned market, and elite independent watchmaking for L.A.

A new partnership combines local infrastructure with global expertise, aiming to streamline development for startups and solidify Singapore's biotech leadership.

From luxury living and senior care to adaptive reuse, Balfour Beatty's projects are transforming Charleston, blending history with future growth.

New AI operating model promises to automate workflows, boost deal flow, and enhance security for investment banks, shifting bankers from data entry to strategy.

As new software gives schools full visibility into student iPads, educators gain powerful safety tools, but critics warn of a new era of classroom surveillance.

Asher House Wellness becomes Lillie&Lee, leveraging its founder's viral rescue fame to build a transparent wellness empire for both pets and people.

Altruist Biologics secures a landmark license for China's largest bioreactor facility, signaling a major shift in the global biopharmaceutical supply chain.

A new partnership aims to solve industrial MRO's biggest challenges with flexible, AI-powered robotics designed to augment, not replace, the workforce.

A new integration aims to solve the manual data headache in private markets, letting investors see their full public and private portfolios in one place.

Ontario Soccer launches a multilingual guide to help newcomers join the game, turning the sport into a powerful tool for community and belonging.

With $80B in AUM, Pzena launches its first active ETFs. Can its classic value approach stand out in the booming, competitive ETF marketplace?

After three rejections, Outlook Therapeutics escalates its fight for US approval of a key wet AMD drug, already sold in Europe. Will the FDA bend?

As U.S.-Mexico trade booms, a new AI platform aims to automate complex customs rules ahead of Mexico's strict 2026 legal reforms, a critical test for shippers.

Thousands of Colorado families with employer-sponsored Anthem plans gain in-network access to top pediatric care, but individual plan members are left out.

Revuze's 'Niche Player' status in Gartner's Magic Quadrant highlights a market shift toward specialized, automated AI that turns customer feedback into action.

The private equity firm signs a landmark lease at 1950 Avenue of the Stars, signaling a new era of growth and impact-focused investment for its second decade.

Major insurers report an 11% drop in prior authorizations, a first step in a larger reform effort. But providers and advocates question if it's enough.